|Mr. Masamichi Terabatake||Pres, CEO & Representative Director||N/A||N/A||1965|
|Mr. Mutsuo Iwai||Pres of Tobacco Bus., Exec. VP & Representative Director||N/A||N/A||1960|
|Mr. Naohiro Minami||CFO, Exec. VP of Communications & Representative Director||N/A||N/A||1964|
|Mr. Kazuhito Yamashita||Sr. VP, Chief Sustainability Officer of Compliance & Gen. Affairs and Director||N/A||N/A||1963|
|Mr. Kiyohide Hirowatari||EVP of Legal, Corp. Strategy, Digitalization, HR, Pharm. Bus. & Food Bus. and Director||N/A||N/A||1965|
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed food in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food business. It offers tobacco products under the Winston, Camel, MEVIUS, and LD brands. The company also researches and develops, manufactures, and sells prescription drugs in the fields of metabolic diseases, viral infection, and autoimmune/inflammatory diseases. In addition, it provides staple food products, such as frozen noodles, frozen and packed cooked rice, and frozen baked bread; bakery products; and seasonings. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
Japan Tobacco Inc.’s ISS Governance QualityScore as of February 3, 2020 is 3. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 6; Compensation: 1.